Author

admin

Browsing

Brazil’s government will give Meta until Monday to explain the changes to its fact-checking program, Solicitor General Jorge Messias said on Friday.

The move comes after the social media company scrapped its US fact-checking program and reduced curbs on discussions around topics such as immigration and gender identity.

It is not immediately clear exactly what will happen after the deadline expires.

“I’d like to express the Brazilian government’s enormous concern about the policy adopted by the Meta company, which is like an airport windsock, changing its position all the time according to the winds,” Messias, the government’s top lawyer, told reporters in Brasilia.

“Brazilian society will not be at the mercy of this kind of policy,” Messias added.

On Thursday, Brazilian President Luiz Inacio Lula da Silva said the changes were “extremely serious” and announced he had called a meeting to discuss the topic.

Meta did not immediately respond to a request for comment.

In announcing the move on Tuesday, CEO Mark Zuckerberg cited “too many mistakes and too much censorship.” A spokesperson said on Tuesday that, for now, Meta was planning the changes only for the US market.

Reuters, which was a Meta partner on its US fact-checking program, has declined to comment.

This post appeared first on cnn.com

Endeavour Silver (TSX:EDR,NYSE:EXK) shared its 2024 production results, reporting output for the period of 4,471,824 ounces of silver and 39,047 ounces of gold, or 7.6 million silver equivalent ounces.

The company met its updated annual production guidance, which it adjusted following operational challenges.

‘After operating at reduced capacity due to the Guanaceví trunnion failure in August, and subsequently resuming full capacity in December, we are satisfied with our production performance in Q4 and producing at the top range of our updated production guidance,’ CEO Dan Dickson said in Thursday’s (January 9) press release.

During Q4, Endeavour produced 824,529 ounces of silver and 9,075 ounces of gold, amounting to 1.6 million silver equivalent ounces. Production was lower during the period due to the trunnion failure at Guanaceví in August.

The trunnion was replaced by late November, and full production capacity was restored in December.

The Guanaceví mine operated at reduced capacity for 15 weeks, averaging only 620 metric tons per day due to the trunnion failure. By December, the plant had returned to its designed throughput of 1,200 metric tons per day.

Meanwhile, steady operations at Bolañitos contributed 105,732 silver ounces and 6,453 gold ounces in Q4. The mine’s gold output exceeded projections due to higher grades, while its silver output remained below plan due to lower grades.

Endeavour’s consolidated production for 2024 reflects an 11 percent decrease in processed throughput compared to 2023. Silver output dropped by 21 percent, while gold production saw a 3 percent increase.

The company sold 4,645,574 silver ounces and 38,522 gold ounces during the year.

In recent financial developments, Endeavour secured US$73 million through a bought-deal financing in November.

The proceeds are designated for general working capital and for advancing the Pitarrilla project.

In 2025, the company will focus on strengthening its production pipeline while managing risks and costs. The restoration of full production capacity at Guanaceví is expected to support steady output in 2025. Progress continues at Endeavour’s development projects, including the Pitarrilla mine in Mexico, which remains a strategic priority.

Shares of Endeavour are up nearly 100 percent year-on-year, but traded lower this week. The company closed Thursday at C$5.21 on the TSX and opened Friday (January 10) at US$3.60 on the NYSE. American markets were closed Thursday.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

China’s Zijin Mining Group (OTC Pink:ZIJMF,SHA:601899) is reportedly in negotiations to acquire a potential controlling interest in Zangge Mining (SZSE:000408), a Chinese lithium producer.

According to Bloomberg, Zijin Mining is looking to purchase stakes from Zangge Mining’s two largest shareholders, Tibet Zangge Venture Capital and Ningbo Meishan Bonded Port Area Xinsha Hongyun Investment Management. Together, they control approximately 40 percent of Zangge Mining, which is valued at 46.6 billion yuan (US$6.4 billion).

Zangge Mining primarily produces potash for fertilizer, but derives around a third of its revenue from lithium extraction. Its lithium operations focus on salt lake brines in Qinghai, China’s mineral-rich western region.

Zangge Mining reported production of 9,278 metric tons of lithium carbonate in the first nine months of 2024.

Zijin Mining, a producer of copper and gold, has been expanding aggressively, with Chairman Chen Jinghe overseeing its transformation from a gold miner in Southeastern China to a global leader in resource extraction.

Acquiring a stake in Zangge Mining would boost Zijin Mining’s position in the lithium market while enhancing its control over the Julong copper project in Tibet, a joint venture between the two companies. Last year, they secured regulatory approval to increase Julong’s output to 350,000 metric tons per day, establishing it as China’s largest single copper mine.

Beyond China, Zijin Mining is also advancing lithium projects abroad.

The company plans to start lithium production in the Democratic Republic of Congo in 2026, although it has postponed the start of its Argentina and Tibet projects to 2025 due to weak lithium prices and permitting delays.

The company’s strategic plan aims for annual production capacity of up to 300,000 metric tons of lithium by 2028. While its current output is limited, the acquisition of Zangge Mining could accelerate its progress toward that target.

Discussions are ongoing and are subject to agreement terms, board approval and regulatory compliance.

Lithium industry M&A heating up

Zijin Mining’s interest in Zangge Mining is part of a trend toward lithium M&A activity.

Major players like Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) have also pursued acquisitions in the lithium space, evidenced by Rio’s US$6.7 billion agreement to acquire Arcadium Lithium (NYSE:ALTM,ASX:LTM) last year.

Lithium remains a critical component in the transition to clean energy, and companies like Zijin Mining are leveraging their expertise in resource development to capture market opportunities.

The lithium market has experienced significant volatility since late 2022, with prices plummeting nearly 90 percent from their peak. However, this downturn in the industry has created opportunities for acquisitions as producers seek to consolidate and optimize operations amid weaker financial conditions.

By expanding its lithium footprint, Zijin Mining is positioning itself to play a key role in the global energy transition.

Zijin Mining is expected to release more details on the potential acquisition in the coming months.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investor Insight

Radiopharm Theranostics represents a promising investment opportunity in the rapidly growing field of radiopharmaceuticals, leveraging its innovative technology platform and diverse clinical pipeline.

Overview

Radiopharm Theranostics (ASX:RAD) is an innovative biopharmaceutical company specializing in the development of radiopharmaceutical products for both diagnostic and therapeutic applications. Founded with a mission to address significant unmet medical needs, particularly in oncology, the company has positioned itself at the forefront of the rapidly evolving field of precision medicine.

Radiopharm Theranostics innovative technology

Radiopharm Theranostics presents a compelling value proposition for investors, characterized by several key factors:

  • Market Positioning: Radiopharm is strategically positioned to capture a significant share of the expanding theranostics market.
  • Diverse Product Pipeline: The company boasts a robust pipeline of radiopharmaceutical products targeting various oncological diseases, which diversifies risk and increases potential revenue streams.
  • Innovative Technology: Radiopharm’s focus on leveraging technological advancements in radiopharmaceuticals, particularly in treating oncological diseases, positions it at the cutting edge of medical innovation.
Radiopharm Theranostics partnership with Lantheus

Lantheus’ investment in Radiopharm marks a pivotal moment for both companies and holds substantial implications for the field of theranostics. The funding will facilitate Radiopharm’s research and development efforts, accelerating its product pipeline and market presence. Under the agreement, Radiopharm will transfer two early preclinical assets to Lantheus for a further AU$3 million, fostering a collaborative relationship focused on radiopharmaceutical development. The collaboration positions Radiopharm to capitalize on the increasing demand for theranostic solutions, aligning with trends in personalized medicine. Moreover, this financial backing will support clinical trials and operational needs, while also aiming for the commercialization of their products.

Company Highlights

  • Radiopharm Theranostics is focused on developing and commercializing radiopharmaceutical products and nuclear medicines for both therapeutic and diagnostic applications in precision oncology.
  • Radiopharm has four licensed platform technologies – nanobody, peptide, small molecules and monoclonal antibodies (mAb) – with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development.
  • The company has received clearance from the US Food and Drug Administration for an investigational new drug application with two INDs (one for RAD 301 and one for RAD 101). Phase 1 for RAD 301 and for RAD 204 is in progress.
  • The company aims to commercialize its pipeline for possible licensing and distribution agreements and has secured four platform technologies, which it is seeking to develop for the diagnosis and treatment of certain cancers.
  • Radiopharm owns 75 percent interest in Radiopharm Ventures, a joint venture created with The University of Texas MD Anderson Cancer Center.

Technology and Clinical Pipeline

Radiopharm has four licensed platform technologies – nanobody, peptide, small molecules and monoclonal antibodies (mAb) – with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development.

Radiopharm Theranostics imaging process

Radiopharm’s clinical stage development in the pipeline include:

  1. PD-L1 (non-small cell lung cancer indication) – currently in phase 1 in Australia;
  2. HER2 (breast/gastric cancer indication) – will begin phase 1 trials this year;
  3. Integrin VB6 (pancreatic cancer indication) – now in Phase I imaging in pancreatic cancer.
  4. Fatty Acid Synthase (brain METS indication) – preclinical has been completed and with IND approval for Phase IIb Imaging

The company recently received FDA approval for its investigational new drug application for 18-Pivalate (RAD 101). Labelled with the radioisotope F18, Pivalate is a small molecule that targets fatty acids synthase, which is overexpressed in brain tumours but not in normal cells.

Positive data from the company’s Phase 2 imaging trial of 17 patients with brain metastases has shown significant tumour uptake. Radiopharm holds an exclusive global license for the Pivalate platform.

Radiopharm Theranostics cancer cell targeting with Pivalate

Radiopharm highlights that Pivalate is potentially a new target for radiopharmaceutical brain imaging agents, and its unique mechanism of action may offer eligible patients a better option in relation to current imaging technology, which has many limitations.

Management Team

Paul Hopper – Executive Chairman

Paul Hopper is the founder of Radiopharm Theranostics. He has over 25 years of experience in the biotech, healthcare and life sciences. Focused on start-up and rapid-growth companies, he has served as the founder, chairman, non-executive director or CEO of more than 15 companies in the US, Australia and Asia. Previous and current boards include Imugene, Chimeric Therapeutics, Viralytics, Prescient Therapeutics and Polynoma. His experience covers extensive fund raising in US, Australia, Asia and Europe, and he has deep experience in corporate governance, risk management, and strategy.

Riccardo Canevari – Managing Director and Chief Executive Officer

Riccardo Canevari has broad and deep experience across specialty pharma, oncology and radiopharmaceuticals. He was most recently chief commercial officer of Novartis Advanced Accelerator Applications, one of the leading radiopharmaceutical and nuclear medicine companies, globally. He was responsible for global commercial strategy and country organizations in ~20 countries across North America, Europe and Asia. He was responsible for Lutathera’s in-market growth strategy and execution to build a blockbuster asset and for the pre-launch plan for Lu-PSMA 617 in metastatic prostate cancer. Prior to this, Canevari was senior vice-president and global head, breast cancer franchise for Novartis Oncology since 2017, overseeing the launch of major breast cancer products, including KISQALI and PIQRAY. He also held various management roles with Novartis Pharma and Ethicon/Johnson & Johnson.

Dr. Sherin Al-Safadi – Vice-president, Medical Affairs

Dr. Sherin Al-Safadi is an accomplished industry leader with many years of experience in pharmaceuticals and biotech. Most recently she was vice-president – medical affairs at POINT Biopharma, where she led the strategic and tactical planning for Phase III support and launch preparation of radiopharmaceuticals. She also provided strategic input and leadership for business development and licensing opportunities. She currently serves as co-founder and president at Foundation Amal (Canada-USA), overseeing an executive leadership team of 12 directors and members, who led the successful 2021 cross-border expansion into the USA and spearheaded the development of a successful branding and communication strategy. Al-Safadi holds a PhD in neurobiology from Concordia University, an MBA in entrepreneurship & management from the John Molson School of Business, and a MSc in pharmacology (oncology drug development) from McGill University.

Vimal Patel – Vice-president, CMC

Vimal Patel joins RAD from Orum Therapeutics where he was vice-president, head of CMC and supply chain. He was responsible for all CMC functions including process and analytical development, manufacturing, quality control, quality assurance, regulatory and supply chain. He led the successful manufacture of two ADCs and contributed to filing an IND leading to a Phase-I trial. Prior to Orum, Patel held roles of increasing responsibility in process development and manufacturing sciences at several companies, including Actinium Pharmaceuticals. Patel also held a position at Pfizer where he contributed to the refiling of Mylotarg and the filing of Besponsa BLAs. He also developed manufacturing processes for various ADCs. He also held roles at Daiichi Sankyo, Progenics Pharmaceuticals and SibTech in various capacities. Patel has MS in biotechnology from University of Connecticut and B.S. in chemical engineering from Sardar Patel University.

Noel Donnelly – Non-executive Director

Noel Donnelly brings more than 25 years of leadership experience in finance, strategy and operations within the biopharmaceutical and biotechnology industries. He has a distinguished track record of building and leading cross-functional teams, driving corporate governance and executing complex financial strategies that support rapid company. growth. Donnelly is current the chief financial officer of PepGen, where he oversaw the company’s financial strategy through its successful IPO, raising U$120 million and leading subsequent financial efforts that secured an additional US$90 million. Donnelly was previously the CFO of EIP Pharma (now, CervoMed), where he led the company’s IPO plannig phase. He had a 15-year tenure at Takeda/Shire PLC, in various senior roles, where he led critical R&D integrations and oversaw more than US$160 billion in integration planning and execution. He was instrumental in shaping the company’s portfolio management strategy.

This post appeared first on investingnews.com

Disney, Fox and Warner Bros. Discovery have called off plans to launch their sports streaming service, Venu, the companies said in a joint statement Friday.

“After careful consideration, we have collectively agreed to discontinue the Venu Sports joint venture and not launch the streaming service,” they said in the statement. “In an ever-changing marketplace, we determined that it was best to meet the evolving demands of sports fans by focusing on existing products and distribution channels. We are proud of the work that has been done on Venu to date and grateful to the Venu staff, whom we will support through this transition period.”

Venu was first announced in February and intended to combine the live sports assets of Fox, WBD and Disney-owned ESPN. It was initially slated to launch before the start of the NFL season in September, but was delayed in part by a legal challenge from internet TV bundler Fubo, which claimed the platform would be anticompetitive.

Together Disney, Fox and WBD control more than 50% of all U.S. sports media rights, and at least 60% of all nationally broadcast U.S. sports rights, according to the judge on the antitrust case.

The news that it would not launch came as a shock to Venu employees, who found out late Thursday night, according to people familiar with the matter. They believed they had a pathway forward to launch the service after Disney agreed earlier this week to merge its Hulu+ Live TV with Fubo, settling all litigation over Venu.

But the judge’s response in Fubo’s lawsuit questioned the legality of cable bundling in general, prompting Disney to strike the deal with Fubo, through which Disney would take 70% control of the resulting company. And two days ago, satellite providers DirecTV and Dish sent letters to federal court arguing that the legal questions brought up by the judge remained unanswered.

Rather than risk an extended lawsuit that could jeopardize bundling in general — including Disney’s efforts to bundle its own streaming entities (ESPN, Hulu and Disney+) — the three companies decided to pull the plug on Venu, according to people familiar with the company’s decisions.

Warner Bros. Discovery’s business model relies heavily on negotiating bundled carriage agreements for its many cable networks, including CNN, TNT, HGTV and Food Network.

Disney is targeting a debut of ESPN “Flagship,” an all-inclusive ESPN streaming service, for August 2025. The still unnamed ESPN streaming service will including everything that airs on ESPN’s linear network, unlike ESPN+.

Disney’s deal with Fubo, along with the company’s recent carriage renewal with DirecTV, also gives the company new ways to package so-called skinny bundles — narrower selections of channels for less money. This was the idea behind Venu: selling a smaller number of linear channels for less money than traditional cable TV.

Disclosure: Comcast, which owns CNBC parent NBCUniversal, is a co-owner of Hulu.

This post appeared first on NBC NEWS

Tulsi Gabbard, who is President-elect Donald Trump’s choice to be Director of National Intelligence (DNI) in his next administration, has reversed course on a controversial item after lobbying from Republican senators. 

Gabbard revealed on Friday that she believes section 702 of the Foreign Intelligence Surveillance Act (FISA) ‘is crucial for gathering foreign intelligence on non-U.S. persons abroad.’

She previously opposed FISA section 702 re-authorization while serving as a Democrat in the House of Representatives. 

‘We have a very important responsibility to strike a balance between national security to keep the American people safe, while also protecting our constitutionally protected freedoms,’ she said on the House floor in 2018. ‘Let us make this critical choice. Vote to keep our country safe. Vote to uphold our constitutional rights that so many have fought and died to protect.’

In her statement, provided by a Trump transition spokesperson, Gabbard said, ‘This unique capability cannot be replicated and must be safeguarded to protect our nation while ensuring the civil liberties of Americans.’

‘My prior concerns about FISA were based on insufficient protections for civil liberties, particularly regarding the FBI’s misuse of warrantless search powers on American citizens. Significant FISA reforms have been enacted since my time in Congress to address these issues. If confirmed as DNI, I will uphold Americans’ Fourth Amendment rights while maintaining vital national security tools like Section 702 to ensure the safety and freedom of the American people,’ she said. 

The change in Gabbard’s beliefs on the key national security issue was first reported by Punchbowl News. 

It comes after multiple Republican senators made the case to her of the importance of FISA’s section 702. 

Sen. Tom Cotton, R-Ark., chair of the Senate Select Committee on Intelligence, told Fox News Digital in a statement: ‘Tulsi Gabbard has assured me in our conversations that she supports Section 702 as recently amended and that she will follow the law and support its reauthorization as DNI.’

One GOP aide shared that during his meeting with Gabbard, Sen. James Lankford, R-Okla., emphasized how important the authority granted by section 702 is, and how important her navigation of it would be. 

In a podcast appearance earlier this week, Lankford told the Wall Street Journal’s Kim Strassel that there were some issues ‘that people aren’t talking about’ as it relates to Trump’s picks. One of them, he said, was Gabbard and her stance on section 702. 

‘She has voted against what’s called 702 authority every time that she was in Congress and voted against it. Well, now she’s going to be the spokesman for 702 authority. It’s a legitimate question just to say, ‘Okay, how are you going to handle this?’’ he asked. 

Lankford suggested that this is something that matters to other Republican senators. ‘I don’t hear anyone really coming up publicly and saying, ‘I’m adamantly opposed” to Trump’s nominees, he explained. 

But, ‘What I hear is a lot of people saying, ‘Hey, I want to give a fair hearing. I want people to be able to answer questions publicly.’’ 

While most GOP senators are supportive of FISA, some have been vocal critics. ‘Voting to reauthorize FISA 702 without a warrant requirement is difficult to defend. So are those casting such votes—especially if they purport to care about the Fourth Amendment,’ Sen. Mike Lee, R-Utah, wrote on X ahead of the most recent FISA re-authorization. 

Another top critic, Sen. Rand Paul, R-Ky., said in 2023, ‘Using 702, Americans’ communications content and metadata is inevitably swept up and kept in government databases without a warrant. Law enforcement agencies then access Americans’ communications without a warrant.’ 

These Republicans may not be as happy about Gabbard’s change of heart. However, there isn’t any indication that it would harm their support for her as of yet. 

One Republican senate source cast doubt on Gabbard’s new stance, noting that she has been ‘a life-long skeptic of intelligence gathering.’ They suggested it is unlikely that she has ‘completely changed her mind.’ 

A GOP Senate source confirmed to Fox News Digital that conservative senators are encouraged by Senate Majority Leader John Thune, R-S.D., and his apparent desire to confirm Trump nominees on the day he is sworn into office. 

The group is eager to have all national security nominees confirmed on Trump’s first day, they added. 

This post appeared first on FOX NEWS

Aides for Tesla and Space X CEO Elon Musk and tech entrepreneur Vivek Ramaswamy are starting to interview staffers with the federal government for the newly created Department of Government Efficiency (DOGE), according to a new report. 

Representatives for DOGE have had conversations with staffers from more than a dozen federal agencies — including the Treasury Department and the Internal Revenue Service, as well as the Departments of Veterans Affairs, Homeland Security, and Health and Human Services, The Washington Post reported Friday. 

Musk and Ramaswamy are leading DOGE, a blue-ribbon committee separate from the federal government that seeks to address issues concerning government spending, waste, efficiency and operations. They are expected to suggest executive actions for the Trump administration and partner with the Office of Management and Budget (OMB) to initiate reforms. 

Altogether, the committee aims to cut $2 trillion from the federal government budget through efforts to slash spending, government programs and the federal workforce. 

However, Musk recently cast doubt on the likelihood of eliminating $2 trillion from the federal budget and said there was a better chance at cutting $1 trillion. 

‘I think we’ll try for $2 trillion. I think that’s like the best-case outcome,’ Musk said during tech trade show CES on Wednesday in Las Vegas, the Post reported. ‘But I do think that you kind of have to have some overage. I think if we try for $2 trillion, we’ve got a good shot at getting $1 [trillion].’

Lawmakers on Capitol Hill have voiced support for working with DOGE, and Reps. Aaron Bean, R-Fla., and Pete Sessions, R-Texas, announced the creation of the Delivering Outstanding Government Efficiency (DOGE) Caucus last year. 

‘Our national debt has surpassed a staggering $36 trillion and should be a wakeup call for all Americans,’ House DOGE Caucus Co-Chair Bean said in a statement in November. ‘We must take action to avoid diving headfirst off the cliff of fiscal ruin. I’m thrilled with President-elect Trump’s appointment of Elon Musk and Vivek Ramaswamy to lead DOGE, but taking on Crazy Town will be no easy task — they will need partners.’

Likewise, Sen. Joni Ernst, R-Iowa, is slated to oversee the Senate DOGE Caucus.

‘The tables are finally turning, the knives are out, and waste is on the chopping block,’ Ernst said in a November statement. 

Currently, DOGE boasts a staff of approximately 50 people who are working from SpaceX’s offices in Washington, D.C., and it is aiming to roughly double that number when President-elect Trump is sworn into office on Jan. 20, according to the Post. 

A representative for Ramaswamy declined to provide comment to Fox News Digital.

DOGE appears to be the source of inspiration for other similar initiatives at the state level. For example, Republican Gov. Kelly Ayotte of swing state New Hampshire on Thursday announced the creation of the Commission on Government Efficiency, known as COGE.

‘COGE will make us smarter than ever before when it comes to saving taxpayer dollars and finding better ways to serve the people of our state,’ Ayotte said in her inaugural address. 

This post appeared first on FOX NEWS

Democratic lawmakers were noticeably silent following the sentencing of President-elect Donald Trump despite previously commenting on the cases against him, as Washington prepares for a Republican trifecta in Congress.

Trump was sentenced on Friday after being found guilty on 34 charges related to falsifying business records in May.

The incoming president was sentenced to unconditional discharge, which means that he will not receive any jail time, fine or probation time. The sentence also preserves Trump’s ability to appeal the conviction. 

After Trump was found guilty in criminal court in May, Democratic members of Congress put out a flurry of reactions on social media but appeared mum after the sentencing on Friday, which comes just days before he will be sworn into office on Jan. 20. 

House Minority Leader Hakeem Jeffries, D-N.Y., in May, wrote in a post on X, fomerly Twitter, that ‘the jury has spoken and carefully rendered a decision. Responsible leadership requires the verdict to be respected,’ while Rep. Alexandria Ocasio-Cortez of New York said that ‘nobody is above the law.’

However, Democrats appeared less reactive to Friday’s sentencing, which left Trump free of any penalty.

One Democratic congresswoman put out a statement following the unconditional discharge sentence, claiming that ‘our system of justice is not just.’

‘There is a two-tiered system of justice in this country, and Donald Trump lives on the tier where he gets to walk into the White House without spending a single day in jail or being put on probation after being convicted of 34 felonies. On the other tier are the clients I represented as a public defender in Texas, like the seventeen-year-old boy who was held on felony probation for taking some candy from his school’s concession stand,’ Rep. Jasmine Crockett, D-Texas, said in a post on X. 

‘The scales are not equal,’ she added.

On the flip side, Republicans were very vocal following the sentencing. 

‘I have no respect for the process being used in New York. I find the judge and prosecutor’s motives to be dripping with politics,’ Sen. Lindsey Graham, R-S.C., said in a statement. ‘This is a sad day for America.’

Trump, ahead of the sentencing, said that he would appeal the decision.

Trump filed an emergency petition to the Supreme Court on Wednesday in an effort to prevent his Jan. 10 sentencing, but the high court ultimately denied his emergency petition to block his sentencing.

Fox News’ Brooke Singman contributed to this report.

This post appeared first on FOX NEWS

Battery and critical metals explorer and developer, Pan Asia Metals Limited (ASX: PAM) (“PAM” or ”the Company”) is pleased to advise that it has entered into a binding Capital Commitment Agreement (“Facility”) with New York based Global Emerging Markets Group for a 4 year $35 million equity investment commitment, providing PAM with a reliable source of equity funding to see it through to JORC Resource and Pre-Feasibility at its Rosario Copper and Tama Atacama Lithium projects.

Highlights

  • 4 Year $35 Million equity investment via Capital Commitment Agreement (Facility) secured.
  • Facility with Global Emerging Markets Group, a $3.4 billion alternative assets management group.
  • Facility significantly reduces PAM’s capital raising risks but maintains PAM’s capital raising flexibility.
  • Facility structured to incentivise GEM to build value in PAM, with equity commitments at fixed pricing reflecting traditional capital raising structures.
  • Facility potentially funds PAM through to Resource and Preliminary Feasibility at Rosario Copper and Tama Atacama Lithium Projects.
  • PAM will seek shareholder approval to rename the Company ‘Flagship Minerals Limited’.

Pan Asia Metals’ Managing Director, Paul Lock, commented:

“We have been working on this Capital Commitment Agreement with GEM for several months and have found the GEM team constructive and collegiate. The facility provides PAM a pathway to Resource definition and pre-feasibility at both the Rosario Copper and Tama Atacama Lithium projects, as well as working capital for the Company’s other needs. I am also pleased to put forward to our shareholders a proposal for a company name change to Flagship Minerals Limited. We are seeking the name change as we have noticed confusion from investors regarding the Company’s geographic focus.”

The Company will also seek shareholder approval to be renamed Flagship Minerals Limited. The name change marks a break in PAM’s exclusive geographic focus on Asia.

Global Emerging Markets (“GEM”) is a $3.4 billion alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world, having completed over 570 transactions in 70 countries. GEM’s investment vehicles provide the group and its investors with a diversified portfolio of asset classes that span the global private investing spectrum. Each investment vehicle has a different degree of operational control, risk-adjusted return and liquidity profile, providing GEM and its partners with exposure to Small-Mid Cap Management Buyouts, Private Investments in Public Equities (PIPE’s) and select venture investments.

The GEM Facility will be primarily employed for Resource definition and preliminary feasibility work at the Company’s Rosario Copper and Tama Atacama Lithium projects. The GEM facility also positions PAM to undertake strategic acquisitions, should appropriate opportunities present.

The PAM Board is of the opinion that the GEM Facility is a transformative step for the Company, providing a pathway for near and medium term funding requirements but not limiting the Company from meeting its capital requirements from other sources, including traditional equity capital and convertible notes.

Key Terms of the GEM Capital Commitment Agreement

The Capital Commitment Agreement between the Company, GEM Global Yield LLC SCS and GEM Yield Bahamas Limited, provides the Company the option, but not the obligation, to draw down up to an aggregate $35 million at any point during the 4 year term of the Facility, subject to certain conditions, including the provision of a drawdown notice to commence a 15 trading days pricing period, with the subscription price being 90% of the higher of:

a. The average closing bid price of PAM shares as quoted by ASX over the pricing period; or

b. A fixed floor price nominated by PAM equal or higher than the closing price immediately preceding the Capital Call; and

the Company’s shares are continuously quoted on ASX during the 15 days prior to the Capital Call. The quantum of the first 3 drawdowns can be for up to $1.5 million each and the following 3 for up to $5 million each for up to an aggregate $19.5 million. The remaining drawdowns and outstanding Facility after the initial 6 drawdowns are limited to 700% of the daily trading volume and GEM may opt to subscribe for 50% to 200% of the drawdown face value provided that any issue of Shares to GEM (or its nominee) would not be a breach of any law or the ASX Listing Rules, including GEM breaching the 19.9% threshold of issued Shares held.

The Company will pay GEM a fee of 2% of the Capital Commitment of $35 million, or A$700,000, within 12 months, exclusive of GST, which is payable in cash and/or shares at the Company’s election. The Company will also issue GEM with 2 tranches of 10 million 5 year call options with a strike price of 12.5c and 20c and expiring 5 years from issue, subject to Shareholder approval.

Click here for the full ASX Release

This post appeared first on investingnews.com

Rare earth elements (REEs) are crucial for technologies like smartphone cameras and defense systems.

A select few from the group of 17 are also vital to the expanding electric vehicle industry — neodymium and praseodymium are used in permanent magnet synchronous motors used in EV drive trains.

China’s dominance in rare earth production and reserves has prompted countries like the US, Canada and Australia to boost their own mining and processing efforts to secure their supply chains. The pressure on these nations to establish strong supply chains is likely to grow when a US tariff on imports of Chinese rare earth magnets begins in 2026.

The 25 percent tariff, announced by the US government in May 2024, aims to both protect American industries from China’s trade practices and support domestic production. One form of magnets the tariffs will affect is sintered neodymium-iron-boron (NdFeB) magnets, crucial for electric vehicle motors and wind turbines.

This marks the first time rare earth magnets are included in Section 301 tariffs, signaling a significant move in the US-China trade conflict. The initiative is part of broader efforts to bolster US energy and national security.

Meanwhile, the EU is also seeking to reduce its reliance on Chinese rare earths through a new law enacted in May, which aims to significantly boost domestic production of critical minerals, including rare earths, by 2030.

In early July, China’s State Council introduced new regulations to tighten control over the country’s rare earth resources and secure its supply chain. Taking effect on October 1, 2024, these new rules impose strict oversight on the mining, smelting and trading of rare earth elements. They also ban the export of technology for extracting and separating rare earths as well as for making rare earth magnets.

US rare earths stocks

To circumvent Chinese tariffs, the US is striving to secure a stable domestic supply of REEs outside China. The US has vast rare earths reserves and is the second largest global REE producer thanks to its sole operating mine, Mountain Pass. However, it currently lacks sufficient processing facilities. American rare earth companies are working to address this imbalance, presenting investment opportunities for those looking to capitalize on the market’s growth potential.

Learn more about MP Materials, Energy Fuels and NioCorp Developments, the three largest US rare earths stocks by market cap, below.

1. MP Materials (NYSE:MP)

Company Profile

Market cap: US$2.9 billion
Share price: US$17.54

MP Materials, the largest producer of rare earths outside China, focuses on high-purity separated neodymium and praseodymium (NdPr) oxide, heavy rare earths concentrate, lanthanum, and cerium oxides and carbonates.

The company went public in mid-2020 after acquiring the Mountain Pass mine in California, the only operational US-based rare earths mine and processing facility. In Q3 2023, MP Materials began producing separated NdPr, marking a significant milestone. The company plans to increase rare earth oxide production by 50 percent within four years.

In April, MP Materials was awarded US$58.5 million to support the construction of the first fully integrated rare earth magnet manufacturing facility in the US. This funding, part of the Section 48C Advanced Energy Project tax credit, was granted by the IRS and Treasury following a selection process that evaluated around 250 projects based on their technical and commercial viability, as well as their environmental and community impact.

Located in Fort Worth, Texas, the facility will produce the NdFeB magnets crucial for EVs, wind turbines and defense systems. The company is targeting commercial production by late 2025. MP Materials will source raw materials from its Mountain Pass mine, creating an end-to-end supply chain with integrated recycling.

During the second quarter of 2024, MP reported that NdPr production more than doubled quarter-over-quarter to 272 metric tons. The company expects that output will increase a further 50 percent in the third quarter.

2. Energy Fuels (NYSEAMERICAN:UUUU,TSX:EFR)

Press ReleasesCompany Profile

Market cap: US$914.91 million
Share price: US$5.59

Energy Fuels is a leading US uranium and rare earths company that operates key uranium production centers including the White Mesa mill in Utah and the Nichols Ranch and Alta Mesa projects in Wyoming and Texas.

The company finished the construction of Phase 1 REE separation infrastructure at White Mesa in early 2024, and in June it reported the successful commercial production of separated neodymium-praseodymium that meets the specifications required for REE-based alloy manufacturing.

According to the company, it believes it is the first US company in decades to achieve commercial-scale, on-spec rare earths separation from monazite. The Phase 1 REE separation circuit was completed under budget and is now operating at full capacity. Energy Fuels anticipates commercial production of 850 to 1,000 metric tons of NdPr per year, making it one of the largest outside China.

Additionally, the mill will produce a heavy REE concentrate for pilot-scale tests to potentially develop commercial dysprosium and terbium separation facilities in the future.

Energy Fuels has also made moves to secure sources of monazite sand to process at its White Mesa mill. In 2023, the company acquired the Bahia project in Brazil to potentially supply 3,000 to 10,000 MT of REE-bearing monazite sand annually.

In early June 2024, Energy Fuels executed a joint venture with Astron (ASX:ATR) for Astron’s Donald rare earth and mineral sands project in Victoria, Australia, of which Energy Fuels now has the option to earn 49 percent. After garnering shareholder approval, the joint venture was finalised in late September. Donald is expected to begin production as early as 2026 and supply the White Mesa mill with 7,000 to 8,000 MT of monazite sand in rare earth concentrate annually in Phase 1, with plans to expand output in subsequent phases.

Adding to its rare earth roster, Energy Fuels announced plans to acquire Australian mineral sands company Base Resources (ASX:BSE) in September.

Commenting on the deal and the new assets, Energy Fuels CEO Mark Chalmers highlighted the rare earth portfolio potential. “The Toliara, Bahia and Donald projects are expected to become large-scale, world-class, and low-cost heavy mineral sand projects in the coming years, producing titanium, zirconium and rare earth minerals,” he said.

3. NioCorp Developments (NASDAQ:NB)

Press ReleasesCompany Profile

Market cap: US$77.32 million
Share price: US$2.00

NioCorp Developments is advancing its Elk Creek project in Nebraska, a leading critical minerals venture featuring North America’s highest-grade niobium deposit under development, with significant scandium production capacity. An updated 2022 feasibility study highlighted extended mine life, improved ore grades and enhanced economics for niobium, scandium and titanium.

Recent metallurgical testing has demonstrated the ability to produce high-purity magnetic rare earth oxides at a recovery rate of 92 percent or higher. These results will inform an updated feasibility study, expected in 2024, incorporating rare earth elements into the project’s mineral reserves.

In April, the company delisted from the TSX due to significantly lower trading volumes than its NASDAQ listing.

A day later, NioCorp announced plans to explore the feasibility of integrating the recycling of permanent rare earth magnets into its proposed Elk Creek critical minerals project in Southeast Nebraska. An assessment will be undertaken to better understand the technical and commercial viability of recycling post-consumer neodymium-iron-boron magnets back into separated rare earth oxides, which can then be utilized in the production of new NdFeB magnets.

The initial phase of this investigation will involve bench-scale testing, with potential progression to demonstration-scale testing based on results. Notably, this initiative will be conducted independently of NioCorp’s ongoing efforts to update its Elk Creek project’s feasibility study.

In May, the company shared the results of a scoping study focused on using a Railveyor system to electrify the Elk Creek mine, which the study found could cut costs, shorten the timeline to full commercial production and lower the mine’s carbon footprint. The system would deliver ore to processing facilities using a narrow-gauge light rail system.

In the preliminary fiscal year financial results released on August 26, NioCorp reported a net loss of US$11.395 million, or US$0.30 per share. The results for the period ending June 30, 2024, marked a year-over-year improvement compared to the previous fiscal year’s loss of US$40.08 million, or US$1.34 per share.

Canadian rare earths stocks

As part of Canada’s Critical Minerals Strategy, the government has allocated C$3.8 billion in federal funding for opportunities across the critical minerals entire value chain, from exploration to recycling. Rare earth elements are among the minerals listed as critical.

Additionally, the government designated C$7.5 million in funding to support the establishment of a rare earths processing facility in Saskatoon, Saskatchewan. In mid-September, the Saskatchewan Research Council (SRC) announced that the facility reached commercial-scale production, making it the first in North America to achieve this milestone.

Currently, the facility produces 10 metric tons of neodymium-praseodymium metals per month. The SRC plans to increase monthly production to 40 MT by December, with an annual goal of 400 MT by early 2025.

Learn about Aclara Resources, Ucore Rare Metals and Mkango Resources, the three largest Canada-listed rare earths stocks by market cap, below.

1. Aclara Resources (TSX:ARA)

Press ReleasesCompany Profile

Market cap: C$83.2 million
Share price: C$0.49

Aclara Resources is advancing its Penco Module project in Chile, characterized by ionic clays abundant in heavy rare earths. Their objective is to generate rare earths concentrate utilizing an environmentally friendly extraction process. This approach aims to eliminate the need for a tailings facility, minimize water consumption and ensure the absence of radioactivity in the final product.

Additionally, the company discovered its Carina Module project in 2023, and in December disclosed an initial inferred resource for the project, encompassing approximately 168 million MT with a grade of 1,510 parts per million total rare earth oxides and 477 parts per million desorbable rare earth oxides.

Aclara successfully concluded its semi-industrial pilot plant program for the Penco Module in September 2023, yielding 107 kilograms of wet high-purity heavy rare earth concentrate from 120 MT of ionic clays. Full-scale production at the Penco Module is slated to commence in the second quarter of 2027.

On March 1, Aclara received its second patent for an innovative process to extract heavy rare earths from ionic clays in an environmentally friendly manner. The patent, granted in Chile and valid for 20 years, focuses on the circular mineral harvesting process and establishes a fully enclosed flowsheet. The company submitted a new environmental impact assessment for its Penco Module project in June that features an improved design addressing environmental and social concerns.

Aclara and Vacuumschmelze, also known as VAC, penned a memorandum of understanding in early July to jointly pursue a ‘mine-to-magnets’ solution for ESG-compliant permanent magnets. The non-binding agreement aims to meet the rising demand for electric vehicles and clean technologies, addressing the limited and Asia-centric supply of rare earth minerals. The partnership seeks to develop a resilient, ESG-focused supply chain for these critical components.

In an August update, Aclara announced that the Environmental Impact Assessment (EIA) for its Penco Module project was moving to the next approval stage.

Later in the month Aclara signed a memorandum of understanding with the State of Goiás and Nova Roma to expedite the Carina Module project, emphasizing its importance for local development and Brazil’s critical minerals supply. This was followed by the release of an updated preliminary economic assessment for the Carina Module featuring initial capital costs of US$593 million and sustaining capital costs of US$86 million.

2. Ucore Rare Metals (TSXV:UCU)

Company Profile

Market cap: C$37.11 million
Share price: C$0.60

Ucore Rare Metals is focused on the exploration and separation of rare earth elements in Canada and the US. The company owns the Bokan-Dotson Ridge rare earths project in Alaska and is developing a strategic metals complex for processing heavy and light rare earths in Louisiana. Ucore acquired an 80,800 square foot brownfield facility in Alexandria, Louisiana, for developing its first commercial REE processing facility in January.

In Canada, Ucore’s Ontario-based RapidSX demonstration plant, operated by Kingston Process Metallurgy, was commissioned to evaluate the techno-economic advantages, scalability and commercial viability of the RapidSX technology platform for separating and producing REEs like praseodymium, neodymium, terbium and dysprosium. This initiative was supported by a US$4 million award from the US Department of Defense, granted to Ucore’s subsidiary, Innovation Metals, to demonstrate the capabilities of the plant.

In late April, Ucore reported that it tested a mixed rare earth carbonate from Defense Metals’ Wicheeda project and confirmed it was suitable for commercial-scale processing at Ucore’s planned facilities. According to the release, ‘(Wicheeda) is a source of material that can become a fundamental economic and technical component to Ucore’s plan of developing multiple SMC’s across North America.’

On July 9, Ucore announced the execution of a non-binding memorandum of understanding with Cyclic Materials that aims to to qualify Cyclic’s recycled rare earth oxide product in Ucore’s process. This will start with the use of initial trial quantities of Cyclic’s supply to support Ucore’s rare earth demonstration program at its RapidSX facility. Additionally, the agreement positions Cyclic Materials as a potential long-term source for Ucore’s planned facilities in the US and Canada.

In mid-August Ucore and Meteoric Resources (ASX:MEI) signed a memorandum of understanding for Meteoric to supply 3,000 MT of total rare earth oxides from its Caldeira rare earth ionic clay project in Brazil to Ucore’s Louisiana strategic metals complex.

A similar deal was established with Australia’s ABx Group (ASX:ABX) in early September. The agreement will see ABx supply Ucore with mixed rare earth carbonates from its ionic adsorption clay rare earth resource in Northern Tasmania.

3. Mkango Resources (TSXV:MKA)

Press ReleasesCompany Profile

Market cap: C$31.69 million
Share price: C$0.12

Mkango is positioning itself to be a leader in the production of recycled rare earth magnets, alloys and oxides via its 79.4 percent stake in Maginito with partner CoTec Holdings. Mkango also has mineral assets, including the advanced Songwe Hill rare earths project in Malawi.

Mkango’s mineral assets include the previously mentioned advanced Songwe Hill rare earths project in Malawi, which is targeting neodymium, praseodymium, dysprosium and terbium, and its Pulawy rare earths separation project in Poland. It also holds a diverse exploration portfolio in Malawi that host resources such as rare earths, uranium, tantalum and niobium.

At the end of July, Mkango’s wholly owned subsidiaries and the government of Malawi signed a mining development agreement for the Songwe rare earth project confirming the fiscal terms for its development, including a 10 percent interest to Malawi’s government and exemption from custom and excise duties imports and exports.

Maginito owns HyProMag, a firm focusing on rare earth magnet recycling at the Tyseley Energy Park in Birmingham, UK. HyProMag is also the licensee of the Hydrogen Processing of Magnet Scrap (HPMS) process, which demagnetizes and liberates rare earth magnets from scrap.

A pilot plant using a long-loop recycling process underpinned by the HPMS process was just commissioned in July, and commercial operations are anticipated to start in Q1 2025. Additionally, Maginito is expanding HyProMag’s recycling technology to the US through the joint venture HyProMag USA, with a feasibility study underway.

In early June, Mkango announced that HyProMag has entered a non-binding memorandum of understanding with Envipro Holdings, a Japanese recycling and materials trading company, to develop rare earth magnet recycling initiatives in Japan and the UK, including marketing and potentially development of its HyProMag technology in Japan, as well as scrap recycling trials in both countries.

In an August update, Mkango reported that HyProMag will receive 350,125 euros to develop its eco-friendly NeoLeach technology, which will further upgrade metals recovered with HPMS. The funding is part of the 8 million euro GREENE project by the European Commission’s Horizon Europe Programme, aiming to improve the resource efficiency and performance of rare earth permanent magnets.

In early October, Mkango and HyProMag secured 218,932 pounds in government grants for recycling strategies under the Innovate UK initiative to advance its recycling routes.

Australian rare earths stocks

Australia ranks among the globe’s top rare earths producers and possesses the fifth largest reserves of these minerals. The nation is notable for hosting the largest supplier of rare earths outside of China, which also holds the highest market capitalization among Australian rare earths companies.

Learn more about Lynas Rare Earths, Iluka Resources and Arafura Resources, the three largest ASX-listed rare earths stocks focused stocks by market cap.

1. Lynas Rare Earths (ASX:LYC)

Company Profile

Market cap: AU$7.37 billion
Share price: AU$7.80

Lynas Rare Earths is the leading separated rare earths producer outside of China, with operations in Australia, Malaysia and the US. In Western Australia, Lynas operates the Mount Weld mine and concentrator and is ramping up processing at its Kalgoorlie rare earth processing facility.

In mid-2023, Lynas received AU$20 million from the Australian government’s Modern Manufacturing Initiative. This funding supports the Apatite leach circuit project at Lynas’ Kalgoorlie facility. The company marked a pivotal moment in December when the Kalgoorlie facility achieved its first production milestone, signaling the transition from commissioning to full-scale operation.

Additionally, Lynas is working to establish a light rare earths processing facility and a heavy rare earths separation facility in Texas, US. These initiatives not only bolster Lynas’s position but also strengthen the rare earths industry in both Australia and the US.

The company processes mined material at its separation facility in Malaysia. In the March 2024 quarter, Lynas reported strong production rates, including 1,724 metric tons of NdPr, following successful ramp-up efforts in Malaysia. Despite a challenging market with low NdPr prices averaging US$47 per kilogram, quarterly sales revenue reached AU$101.2 million.

In late June, Lynas announced plans to begin production of separated dysprosium and terbium products at its Malaysian operations in the 2025 calendar year.

In August, Lynas reported a 92 percent increase in mineral resources and a 63 percent rise in ore reserves at its Mount Weld site. Mineral resources have expanded from 55.4 million to 106.6 million MT at 4.12 percent total rare earth oxides, while ore reserves have grown from 19.7 million to 32 million MT at 6.44 percent.

The new estimates include significant increases in contained heavy rare earth elements and support a mine life of over 20 years at expanded production rates. Additionally, stored tailings were added to the ore reserves as the operations have the ability to reprocess them to recover additional rare earth minerals.

In its full year fiscal results 2024, Lynas reported an AU$226 million decline in net profit after tax. Company CEO Amanda Lacaze attributed the decrease to a challenging market, lower production tallies and upgrading downtime.

“Whilst NdPr production decreased by 8 percent, in a year when we undertook a major works program at Lynas Malaysia, total costs reduced by 17 percent in FY24 vs FY23, a reflection of the continued focus on capturing efficiencies across the business,” she wrote.

2. Iluka Resources (ASX:ILU)

Company Profile

Market cap: AU$2.91 billion
Share price: AU$6.82

Iluka Resources is advancing its Eneabba rare earths refinery in Western Australia with significant backing from the Australian government, which aims to bolster the country’s footprint in the global rare earths market by tapping into its abundant reserves. The company also owns zircon operations in Australia, including Jacinth-Ambrosia, the world’s largest zircon mine.

Iluka secured an AU$1.25 billion non-recourse loan for Eneabba under the AU$2 billion Critical Minerals Facility administered by Export Finance Australia. This funding will support the development of a fully integrated refinery capable of producing both light and heavy separated rare earth oxides. The facility will process material from Iluka’s own feedstocks and third-party suppliers, with initial production expected to commence by 2025.

Additionally, Iluka is progressing its Wimmera project in Victoria, focusing on mining and beneficiation of fine-grained heavy mineral sands in the Murray Basin. This project aims to supply zircon and rare earths over the long term. A definitive feasibility study for Wimmera is scheduled for completion by the end of 2025.

In the company’s Q2 quarterly results, Iluka noted that Q2 activity at Eneabba included the ‘progression of major engineering packages, conclusion of camp accommodation works and preparation for commencing the next phase of site works.’

On August 21, Iluka released its half year results, which included a AU$106 million revenue decrease compared to the first half of 2023. The company pointed to global macroeconomics, operational and market discipline and capital investments for the reduction.

3. Arafura Resources (ASX:ARU)

Company Profile

Market cap: AU$418.93 million
Share price: AU$0.17

Arafura Resources, an Australian rare earths firm, has secured government funding to advance its Nolans rare earths project in the Northern Territory. Arafura is currently working towards a final investment decision for Nolans, which is shovel ready.

Nolans is envisioned as a vertically integrated operation with on-site processing facilities. A 2022 mine report updates Nolans’ expected lifespan to 38 years, targeting an annual production capacity of 4,440 MT of NdPr concentrate. The project’s definitive feasibility study highlights significant concentrations of neodymium and praseodymium, alongside all other rare earths in varying quantities.

Arafura has inked a binding offtake agreements with Hyundai Motors (KRX:005380), Kia (KRX:000270), and Siemens Gamesa Renewable Energy. Additionally, the company has a non-binding memorandum of understanding with General Electric Company’s (NASDAQ:GE) GE Renewable Energy to collaborate on establishing sustainable rare earths supply chains.

In its update for the June quarter, Arafura noted that it had secured conditional approval for over US$1 billion in debt funding for the Nolans project. With safety preparations underway, Arafura is nearing a final investment decision and is set to begin construction once financing is finalized.

In a late August press release, Arafura announced the signing of a memorandum of understanding with Canada’s Saskatchewan Research Council (SRC) to process rare earths from Arafura’s Nolans project into dysprosium and terbium oxides at SRC’s facility in Canada. The collaboration aims to support global supply chain diversification for energy transition technologies.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com